Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
3-year results show that patients who underwent low-risk aortic valve replacement continue to report lower rates of all-cause mortality and stroke with TAVI compared to surgery
Read Full NewsTrial data showed that treatment with lamotrigine reduced myotonia severity in adults with genetically confirmed non-dystrophic myotonias, with sustained benefit and an acceptable safety profile.
The neurologist in the Department of Neurology at Saratoga Hospital Medical Group shared what excites her most about the future of neurology, specifically for movement disorders, in 2026.
COPD Drug Withdrawal Tied to Early Exacerbation, With Alexander Mathioudakis, MD, PhD
FDA Accepts NDA for Priority Review of Centanafadine to Treat Adult, Pediatric ADHD
FDA Approves Labeling Update for iDose TR for Open-Angle Glaucoma and Ocular Hypertension
Apecotrep Delivers 40% Proteinuria Reduction in Phase 2 FSGS Trial
FDA Approves New Narcan Packaging, Aiming to Boost Carry Rates
1.
A novel test shows promise for finding cervical adenocarcinoma, which is difficult to find.
2.
Experts suggest Michelangelo depicted breast cancer in the Sistine Chapel fresco
3.
Radioiodine therapy found to improve relative survival rates of differentiated thyroid cancer patients
4.
High numbers of rural patients cross state lines for cancer care
5.
Compared to previous estimates, a greater number of patients participate in cancer treatment trials.
1.
How Digital Innovation and AI-Powered Case Studies are Revolutionizing Oncology Education?
2.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
3.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
4.
The Benefits and Risks of Transurethral Resection of Bladder Tumor
5.
The Science Behind Imatinib: How It Targets Cancer Cells
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
4.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge